Navigation Links
Autologous Bone Marrow Stem Cells Transplant into Parkinson's Disease Patients is Safe and May Improve Their Quality of Life
Date:3/11/2010

Clinical study showing a minimally invasive approach was presented in The XVIII World Congress on Parkinson’s Disease and Related Disorders of the World Federation of Neurology.

(PRWEB) March 11, 2010 -- Eight Parkinson’s Disease (PD) patients were treated with their own bone marrow stem cells (BMSC) injected via minimally invasive routes and discharged the next morning without complications.

Evaluations with UPDRS, Hoehn & Yahr scale and Schwab & England score showed encouraging improvements and the total L- dopamine dose could be decreased suggesting that stem cells may enhance endogenous dopamine synthesis. As a matter of sample, the writing test pre versus post procedure showed significant changes.

“It is high time we focused our efforts in what is possible and reachable and what suffering patients demand. Not all what is researched and developed in Petri dishes or rats can automatically be used in patients, so we should stop to augment their confusion. We expect this study in PD real patients, not in animals, draws the attention of those interested in getting clinical data since, funnily enough, there are billions of dollars spent in endless animal studies but very little in clinical ones” leader investigator Dr. Luis Geffner said.

They ought to be very cautious and prudent emphasizing that presently this is a tool that may complement standard treatments and delay the progress of both the illness and the complications of the medication currently used to treat it. PD patients should be cared comprehensively; therefore, their treatment may include physical therapies as well as optimal medication and stem cells transplant, trying to improve their independence and self-care he added.

Geffner’s team has already transplanted 147 patients suffering from different illnesses or trauma states and many of them have been followed up 5 years showing that autologous adult BMSC neither provoke tumors, immunologic rejection, pain, infections nor arise ethical or religious controversies. That is why they stand to push these investigations forward.

This clinical study Transplant of Autologous Bone Marrow Stem Cells into Parkinson’s Disease Patients Is Safe And May Improve Their Quality Of Life by Geffner L et al was shown in Miami on December 15th, 2009 in the XVIII World Congress on Parkinson’s Disease and Related Disorders organized by the World Federation of Neurology and published in December 2009 issue of Parkinson’s Disease and Related Disorders journal.

Dr. Geffner has been working in the field of clinical application of stem cells in many illnesses and conditions and is author of several papers, lecturer in many meetings, consultant for some biological laboratories and has founded the stem cells research in Ecuador in July 2004.

He is in charge of Stem Cells Ecuador, Guayaquil, Ecuador (www.stemcellsecuador.com) and he and his team expect to have new data to publish shortly not only in PD but also in several programs that they are developing in the regenerative medicine field.

###

Read the full story at http://www.prweb.com/releases/2010/03/prweb3707924.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Harvest Technologies Announces Patient Education Website, www.CLIclinicalstudy.com : Supports first randomized, placebo-controlled clinical trial in the U.S. using autologous adult stem cells to treat patients with end-stage Critical Limb Ischemia
2. Autologous stem cell transplantation for soft tissue sarcoma: insufficient research into therapy
3. Women with breast cancer may benefit from autologous stem cell transplantation
4. StemCor Systems Receives FDA Clearance for Bone Marrow Harvesting System
5. Study on Plasma-Depleted Cord Blood Transplantation Receives Best Abstract Award From The National Marrow Donor Program
6. Oral drug sets a new survival standard for bone marrow cancer
7. Bone marrow cell transplants help nerve regeneration
8. StemCor Systems Announces Acquisition of Intellectual Property to Enhance Bone Marrow Aspiration Platform
9. Transplanted Bone Marrow Cells Aid Nerve Regeneration
10. Stem cells make bone marrow cancer resistant to treatment
11. Saturn Celebrates 11 Years of Helping Save Lives Through Blood, Marrow, Organ and Tissue Donation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Autologous Bone Marrow Stem Cells Transplant into Parkinson's Disease Patients is Safe and May Improve Their Quality of Life
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology: